Sewoon Medical Co. Ltd
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical … Read more
Sewoon Medical Co. Ltd (100700) - Net Assets
Latest net assets as of September 2025: ₩150.08 Billion KRW
Based on the latest financial reports, Sewoon Medical Co. Ltd (100700) has net assets worth ₩150.08 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩158.77 Billion) and total liabilities (₩8.68 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩150.08 Billion |
| % of Total Assets | 94.53% |
| Annual Growth Rate | 9.17% |
| 5-Year Change | 43.29% |
| 10-Year Change | 122.69% |
| Growth Volatility | 3.17 |
Sewoon Medical Co. Ltd - Net Assets Trend (2011–2024)
This chart illustrates how Sewoon Medical Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sewoon Medical Co. Ltd (2011–2024)
The table below shows the annual net assets of Sewoon Medical Co. Ltd from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩146.12 Billion | +6.12% |
| 2023-12-31 | ₩137.69 Billion | +11.94% |
| 2022-12-31 | ₩123.01 Billion | +7.77% |
| 2021-12-31 | ₩114.13 Billion | +11.92% |
| 2020-12-31 | ₩101.98 Billion | +7.10% |
| 2019-12-31 | ₩95.22 Billion | +10.27% |
| 2018-12-31 | ₩86.35 Billion | +11.11% |
| 2017-12-31 | ₩77.72 Billion | +6.33% |
| 2016-12-31 | ₩73.09 Billion | +11.40% |
| 2015-12-31 | ₩65.61 Billion | +1.97% |
| 2014-12-31 | ₩64.35 Billion | +9.58% |
| 2013-12-31 | ₩58.72 Billion | +14.58% |
| 2012-12-31 | ₩51.25 Billion | +9.72% |
| 2011-12-31 | ₩46.71 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sewoon Medical Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 13666099664000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩136.66 Billion | 93.53% |
| Common Stock | ₩4.38 Billion | 3.00% |
| Other Components | ₩5.08 Billion | 3.47% |
| Total Equity | ₩146.12 Billion | 100.00% |
Sewoon Medical Co. Ltd Competitors by Market Cap
The table below lists competitors of Sewoon Medical Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Singapore Shipping Corporation Limited
F:W1M
|
$34.09 Million |
|
ONDE S.A. ZY -02
F:0XF
|
$34.11 Million |
|
Intchains Group Limited American Depositary Shares
NASDAQ:ICG
|
$34.13 Million |
|
CHA Vaccine Institute Co. Ltd.
KQ:261780
|
$34.14 Million |
|
Teo Seng Capital Bhd
KLSE:7252
|
$34.06 Million |
|
Kencana Energi Lestari
JK:KEEN
|
$34.05 Million |
|
Virgin Group Acquisition Corp II
NYSE:GROV
|
$34.03 Million |
|
BICECORP S.A
SN:BICECORP
|
$34.02 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sewoon Medical Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 135,156,925,060 to 146,117,692,430, a change of 10,960,767,370 (8.1%).
- Net income of 12,162,591,320 contributed positively to equity growth.
- Dividend payments of 3,030,377,000 reduced retained earnings.
- Other factors increased equity by 1,828,553,050.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩12.16 Billion | +8.32% |
| Dividends Paid | ₩3.03 Billion | -2.07% |
| Other Changes | ₩1.83 Billion | +1.25% |
| Total Change | ₩- | 8.11% |
Book Value vs Market Value Analysis
This analysis compares Sewoon Medical Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.73x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.47x to 0.73x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1688.40 | ₩2480.00 | x |
| 2017-12-31 | ₩1795.22 | ₩2480.00 | x |
| 2018-12-31 | ₩1994.60 | ₩2480.00 | x |
| 2019-12-31 | ₩2199.45 | ₩2480.00 | x |
| 2020-12-31 | ₩2355.58 | ₩2480.00 | x |
| 2021-12-31 | ₩2636.45 | ₩2480.00 | x |
| 2022-12-31 | ₩2841.35 | ₩2480.00 | x |
| 2023-12-31 | ₩3122.05 | ₩2480.00 | x |
| 2024-12-31 | ₩3375.24 | ₩2480.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sewoon Medical Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.32%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 20.22%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 1.07x
- Recent ROE (8.32%) is below the historical average (10.05%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 8.03% | 8.32% | 0.80x | 1.20x | ₩-905.16 Million |
| 2012 | 10.49% | 10.73% | 0.87x | 1.12x | ₩246.23 Million |
| 2013 | 14.73% | 16.57% | 0.80x | 1.12x | ₩2.74 Billion |
| 2014 | 9.46% | 11.33% | 0.72x | 1.15x | ₩-341.79 Million |
| 2015 | 4.67% | 5.49% | 0.71x | 1.20x | ₩-3.50 Billion |
| 2016 | 11.42% | 14.74% | 0.66x | 1.17x | ₩1.04 Billion |
| 2017 | 11.81% | 14.99% | 0.71x | 1.11x | ₩1.41 Billion |
| 2018 | 11.20% | 15.32% | 0.65x | 1.12x | ₩1.04 Billion |
| 2019 | 9.95% | 14.17% | 0.64x | 1.10x | ₩-45.72 Million |
| 2020 | 10.29% | 16.47% | 0.58x | 1.07x | ₩298.00 Million |
| 2021 | 10.76% | 19.63% | 0.50x | 1.09x | ₩868.15 Million |
| 2022 | 8.46% | 17.31% | 0.45x | 1.08x | ₩-1.89 Billion |
| 2023 | 11.07% | 21.92% | 0.47x | 1.08x | ₩1.44 Billion |
| 2024 | 8.32% | 20.22% | 0.38x | 1.07x | ₩-2.45 Billion |
Industry Comparison
This section compares Sewoon Medical Co. Ltd's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.
Industry Context
- Industry: Healthcare Equipment & Supplies
- Average net assets among peers: $96,888,727,364
- Average return on equity (ROE) among peers: -8.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sewoon Medical Co. Ltd (100700) | ₩150.08 Billion | 8.03% | 0.06x | $34.07 Million |
| InBody Co.Ltd (041830) | $183.73 Billion | 18.52% | 0.11x | $208.16 Million |
| MEDIANA Co.Ltd (041920) | $34.91 Billion | 20.29% | 0.27x | $70.69 Million |
| Value Added Technology Co. Ltd (043150) | $349.29 Billion | 22.01% | 0.46x | $109.99 Million |
| MEKICS Co Ltd (058110) | $7.87 Billion | -24.74% | 1.89x | $14.44 Million |
| Meta Biomed Co. Ltd (059210) | $39.05 Billion | 3.02% | 0.38x | $50.83 Million |
| INFINITT Healthcare Co. Ltd (071200) | $77.28 Billion | 6.38% | 0.20x | $53.10 Million |
| i-SENS Inc (099190) | $118.81 Billion | 12.18% | 0.38x | $127.37 Million |
| CU Medical Systems Inc (115480) | $58.36 Billion | 16.15% | 0.51x | $14.81 Million |
| PeopleBio Inc (304840) | $2.70 Billion | -148.07% | 0.61x | $5.72 Million |